3Chopt Investment Partners’s Bristol-Myers Squibb BMY Stock Holding History
Bought
Maintained
Sold
Other funds holding BMY
AIM
FWIA
3Chopt Investment Partners's BMY Position: Q2 2026 in Review
3Chopt Investment Partners opened a new position in Bristol-Myers Squibb (BMY) in Q2 2026: 11,859 shares worth $683K. The stake represents 0.13% of the portfolio and ranks #130 among its holdings. This is a return to the name: 3Chopt Investment Partners previously reported a position in BMY as recently as Q4 2025.
3Chopt Investment Partners first reported a position in BMY in Q4 2022 and has held it in 14 quarters since. The position peaked at $3.48M in Q1 2025. 1,158 funds tracked by Wall St. Rank hold BMY as of Q2 2026.
- 3Chopt Investment Partners held 11,859 shares of Bristol-Myers Squibb worth $683K as of Q2 2026.
- Bristol-Myers Squibb was a new 3Chopt Investment Partners position in Q2 2026.
- Bristol-Myers Squibb made up 0.13% of 3Chopt Investment Partners's portfolio in Q2 2026, its #130 holding.
- 3Chopt Investment Partners first reported a position in Bristol-Myers Squibb in Q4 2022 and has held it in 14 quarters since.
- 3Chopt Investment Partners's Bristol-Myers Squibb position peaked at $3.48M in Q1 2025.
- 1,158 funds tracked by Wall St. Rank held Bristol-Myers Squibb as of Q2 2026.
Based on 3Chopt Investment Partners's 13F filing for Q2 2026, filed 29 Jul 2026.